What's already known about this topic? With the recent development of high‐throughput genome‐wide technologies, access to comprehensive chromosome screening has improved the clinical outcomes of preimplantation genetic testing. However, only a few studies have reported clinical applications of these methods to differentiate normal embryos from balanced translocation carriers. What does this study add? This study reports the clinical applications to distinguish embryos carrying Robertsonian translocations, simultaneously with CCS, based on a single nucleotide polymorphism array platform. It offers a feasible approach to identify normal embryos and carriers. Finally, the results of this study could prevent Robertsonian translocations from being passed to subsequent generations.